By promoting the degradation of mRNAs encoding certain immune evasion molecules and antigens, YTHDF2 may enhance tumor cell recognition by immune cells and improve their susceptibility to immune-mediated clearance. The gene discussed is YTHDF2; the disease is neoplasm.